Acetaminophen group (n = 308) | Placebo group (n = 135) | p-value* | |
---|---|---|---|
Age: | |||
Mean ± SD | 43 ± 9 | 44 ± 8 | 0.399 |
Range | 18–72 | 20–65 | |
Male (%) | 284 (92) | 128 (95) | 0.322 |
Ethnic Origin (%): | |||
Caucasian | 156 (51) | 68 (50) | 0.830 |
Hispanic | 45 (15) | 22 (16) | |
African Descent | 49 (16) | 16 (12) | |
Native American | 43 (14) | 23 (17) | |
Other | 15 (5) | 6 (4) | |
Body Mass Index: | |||
Mean ± SD | 25 ± 5 | 25 ± 4 | |
Range | 15–55 | 17–39 | |
Breath alcohol level at presentation to detoxification site: | 0.711 | ||
Mean ± SD | 0.161 ± 0.093 | 0.157 ± 0.099 | |
Range | 0.001–0.710 | 0.001–0.550 | |
Self-reported alcoholic (%) | 301 (98) | 133 (99) | 0.729 |
Duration of most recent drinking binge: | |||
< 1 week | 56 (18) | 22 (16) | 0.193 |
1–4 weeks | 98 (32) | 36 (27) | |
> 1 month | 154 (50) | 76 (56) | |
Not reported | 0 (0) | 1 (1) | |
CAGE (no. of yes answers; mean ± SD) | 3.3 ± 0.9 | 3.3 ± 0.9 | 0.645 |
Alanine aminotransferase: | |||
mg/dL | 49 ± 38 | 47 ± 37 | 0.398 |
Range | 4–189 | 8–175 | |
Aspartate aminotransferase: | |||
IU/L | 55 ± 39 | 55 ± 38 | 0.650 |
Range | 6–198 | 12–194 | |
International normalized ratio: | 0.652 | ||
INR | 0.96 ± 0.09 | 0.96 ± 0.09 | |
Range | 0.79–1.40 | 0.80–1.30 | |
Albumin: | 0.589 | ||
g/dl | 3.94 ± 0.45 | 3.93 ± 0.37 | |
Range | 2.1–4.8 | 2.8–4.0 | |
Total bilirubin: | |||
mg/dL | 0.74 ± 0.53 | 0.68 ± 0.45 | 0.286 |
Range | 0.1–4.1 | 0.1–2.8 | |
Gamma glutamyl transferase: | |||
IU/L | 161 ± 308 | 168 ± 274 | 0.799 |
Range | 9.0–3492 | 12.0–1893 |